Human vaccinia virus immune globulin Completed Phase 2 Trials for Vaccinia Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00081835
Evaluation and Treatment of Eye Complications of Vaccinia Vaccination